Reddy KS, Jain V, Varatharajan S, Pallavali JR. Vitamin D, selenium in type 2 diabetes and Hashimoto's thyroiditis: Is it effective? World J Diabetes 2024; 15(5): 1048-1050 [PMID: 38766428 DOI: 10.4239/wjd.v15.i5.1048]
Corresponding Author of This Article
Kotha Sugunakar Reddy, MBBS, MD, Doctor, Occupational Physician, Department of General Medicine, All India Institute of Medical Sciences, Bibinagar, NH 163, Hyderabad Metropolitan Region, Yadadri Bhuvanagiri District, Telangana, Hyderabad 508126, India. sugs.doc@gmail.com
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Kotha Sugunakar Reddy, Vishakha Jain, Sakthivadivel Varatharajan, Janardhana Reddy Pallavali, Department of General Medicine, All India Institute of Medical Sciences, Telangana, Hyderabad 508126, India
Author contributions: Reddy KS designed and formulated the research; Reddy KS, Jain V, Varatharajan S performed study; Reddy KS, Pallavali JR analyzed data; Reddy KS wrote the letter; Jain V, Varatharajan S revised the letter.
Conflict-of-interest statement: The Authors declare that there are no potential conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kotha Sugunakar Reddy, MBBS, MD, Doctor, Occupational Physician, Department of General Medicine, All India Institute of Medical Sciences, Bibinagar, NH 163, Hyderabad Metropolitan Region, Yadadri Bhuvanagiri District, Telangana, Hyderabad 508126, India. sugs.doc@gmail.com
Received: March 3, 2024 Revised: April 3, 2024 Accepted: April 10, 2024 Published online: May 15, 2024 Processing time: 67 Days and 20.2 Hours
Abstract
The study by Feng et al, explores treatment approaches for these coexisting conditions. It emphasizes the potential advantages of selenium and vitamin D supplementation but also raises methodological and patient selection concerns. Findings indicate a complex interplay between interventions and disease markers, prompting the need for further research. Despite limitations, the study offers valuable insights into managing the intricate relationship between type 2 diabetes mellitus and Hashimoto's thyroiditis. The authors' contributions shed light on potential treatment avenues, although careful consideration of study design and patient characteristics is warranted for future investigations in this domain.
Core Tip: A study on vitamin D, selenium, and antidiabetic drugs' role in managing type 2 diabetes mellitus with Hashimoto's thyroiditis: Highlights the potential benefits of selenium and vitamin D supplementation and it need to address concerns about methodology and patient selection. The study prompts further investigation into the relationship between interventions and disease markers, urging caution in interpreting findings. It acknowledges the study's valuable insights but underscores the need for clearer methodology and consideration of potential biases. Overall, it emphasizes the importance of rigorous research in understanding and managing these complex conditions.
